Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial

OBJECTIVE: To compare efficacy and safety of insulin glargine 300 units/mL (Gla-300) and 100 units/mL (Gla-100) in children and adolescents (6–17 years old) with type 1 diabetes. RESEARCH DESIGN AND METHODS: EDITION JUNIOR was a noninferiority, international, open-label, two-arm, parallel-group, pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Danne, Thomas, Tamborlane, William V., Malievsky, Oleg A., Franco, Denise R., Kawamura, Tomoyuki, Demissie, Marek, Niemoeller, Elisabeth, Goyeau, Harmonie, Wardecki, Marek, Battelino, Tadej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305011/
https://www.ncbi.nlm.nih.gov/pubmed/32430458
http://dx.doi.org/10.2337/dc19-1926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305011/
https://www.ncbi.nlm.nih.gov/pubmed/32430458
http://dx.doi.org/10.2337/dc19-1926

Ejemplares similares